Trilostane
Advanced Hormonal Therapy for Cushing's Disease
Trilostane is a breakthrough medication widely used in modern veterinary medicine for the treatment of Cushing's Disease (hyperadrenocorticism) in dogs and cats. As a synthetic enzyme-inhibiting drug, it works by blocking the excess production of cortisol, a stress hormone produced by the adrenal glands. By restoring hormonal balance, trilostane helps control the debilitating symptoms of this condition and greatly improves overall quality of life.
How Trilostane Works
Trilostane inhibits the enzyme 3-beta-hydroxysteroid dehydrogenase, which is essential for cortisol synthesis. By reducing cortisol levels, it directly targets the underlying cause of:
- Persistent thirst and urination
- Hair loss and thin coat
- Muscle weakness
- Pot-bellied appearance
- Chronic skin infections
This targeted mechanism makes trilostane one of the most effective treatment options available today.
Indications and Usage
Trilostane is often recommended for:
- Pituitary-Dependent Cushing's Disease (PDH) - The most common type is caused by a pituitary tumor overstimulating the adrenal glands.
- Adrenal-dependent Cushing's disease (ADH) - A less common kind produced by an adrenal tumor.
- Alopecia X - A hormone-related hair loss disorder in which trilostane may aid in coat growth.
Administration
- Given normally, generally with food.
- Effects often occur within 1-2 days.
- Regular ACTH stimulation testing is required to guarantee accurate dose and minimize problems.
Proven Efficacy and Survival Benefits
Numerous veterinary investigations have shown trilostane's safety and efficacy. One important study discovered:
- Dogs with untreated PDH lived an average of 506 days.
- Dogs treated with trilostane (1-3 mg/kg once or twice daily) had considerably greater survival rates, with the median survival time not attained during the research.
This emphasizes trilostane's potent ability to slow disease progression and increase life expectancy.
Possible Side Effects and Monitoring
While most pets tolerate trilostane well, some may develop:
- Lethargy or weakness
- Vomiting or diarrhea
- Decreased appetite
- Shaking or trembling
A rare but deadly complication is an Addisonian crisis, which occurs when cortisol levels go too low.
Continuous monitoring is needed . Veterinarians frequently urge follow-up testing after 10-14 days, 30 days, 90 days, and every 3-6 months thereafter.
Availability & Formulations
- Standard oral capsules
- Flavored chewable tablets
- Gelatin or vegetable capsules
- Water-based oral suspensions with customizable flavors
It should be stored in tight, light-resistant containers at room temperature to maintain stability.
Summary
Trilostane has dramatically transformed the treatment of Cushing's Disease in both dogs and cats. By effectively reducing excessive cortisol production, it:
- Improves symptoms
- Enhances quality of life
- Supports longer survival times
Although the medication requires close veterinary supervision and regular testing, its proven results have made it a cornerstone therapy in managing this challenging endocrine condition.